Green Eric Mark 4

What Happened

• Eric Mark Green, President, CEO and Board Chair of West Pharmaceutical Services (WST), received vested performance/restricted stock and completed related conversions/exercises on Feb 17–18, 2026. He was credited with 4,418.771 shares (PSU award/vesting) on Feb 17 and 1,318.81 shares on Feb 18 from a conversion/exercise, for ~5,737.58 shares acquired in total.
• To cover withholding/tax obligations, 1,305.382 shares were disposed on Feb 17 at $243.19 for $317,456 and 573.551 shares were disposed on Feb 18 at $248.26 for $142,390 — combined tax withholding sales of 1,878.933 shares totaling about $459,846.
• The filing also lists a derivative-related line showing a 1,318.81-share conversion/disposition (reported at $0), consistent with a conversion/exercise event and internal reporting of share transfers.

Key Details

• Transaction types: A = Award/vesting (PSUs/RSUs), M = exercise/conversion of derivative, F = shares withheld/sold to pay tax liability.
• Dates/prices/values: 2/17/2026 A: 4,418.771 shares @ $0; 2/17/2026 F: 1,305.382 shares @ $243.19 = $317,456; 2/18/2026 M: 1,318.81 shares acquired; 2/18/2026 F: 573.551 shares @ $248.26 = $142,390; derivative disposition 1,318.81 shares reported at $0.
• Shares withheld/sold for taxes: 1,878.933 shares, ≈ $459,846 in gross proceeds to satisfy tax/withholding obligations.
• Shares owned after transaction: not disclosed in the filing.
• Footnotes: F1 = PSUs vested (2023–2025 performance period) and paid on the transaction date; F2 = RSUs convert 1:1 to common stock; F3 = prior 2025 RSU grant vests in installments.
• Filing timeliness: Form 4 filed Feb 19, 2026 for transactions on Feb 17–18 — within the standard 2-business-day reporting window (timely).

Context

• This appears to be routine insider equity compensation activity: PSUs and/or RSUs vested/converted and a portion of shares was withheld/sold to cover tax obligations (a common cashless-withholding approach). Such withholding/sales are administrative and do not necessarily indicate a buy/sell signal about the company.
• The derivative entries labeled M indicate conversion/exercise of awards; the simultaneous withholding/dispositions are consistent with using shares to satisfy tax/option costs rather than open-market sales.